Meeting
2014 ASCO Annual Meeting
Predictive factors for late (>5 years) distant recurrences in estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer patients: >20-year follow-up.
Authors
Jaskirat Singh Randhawa
Cleveland Clinic/Fairview, Cleveland, OH
Jaskirat Singh Randhawa , Sina Shafiei , Mykola Onyshchenko , Susmita Sakruti , Rohan Garje , Vyshak Alva Venur , Xuefei Jia , Timothy Peter Spiro , Abdo S. Haddad , Hamed Daw
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 543)
DOI
10.1200/jco.2014.32.15_suppl.543
Abstract #
543
Poster Bd #
7
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Utilization of tumor-informed circulating tumor DNA in detecting minimal residual disease and guiding adjuvant therapy in liver cancer.
First Author: De-Zhen Guo
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Preoperative risk factors related to relapse-free survival after R0 resection of gallbladder cancer.
First Author: Sang Hun Lee
Poster
2022 ASCO Annual Meeting
Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer.
First Author: Sung Jun Ma
Poster
2021 ASCO Annual Meeting
Clinical validation of EndoPredict in premenopausal women with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) primary breast cancer.
First Author: Anastasia Constantinidou